Loading clinical trials...
Loading clinical trials...
The objective of this pilot study is to evaluate the prevalence of biological aspirin resistance in women at risk for CHD taking low dose (81 mg) aspirin. Aspirin responsiveness will be measured with ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Creighton University
NCT06675552 · Heart Disease, Heart Failure, and more
NCT07165678 · Coronary Heart Disease
NCT04761120 · Mitral Regurgitation, Tricuspid Regurgitation, and more
NCT05783375 · Rheumatic Heart Disease
NCT06145035 · Ischemic Heart Disease
The Cardiac Center at Creighton University
Omaha, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions